Top 20 Urology Devices Manufacturers

1. Report Overview 1.1 Global Urology Device Market Overview 1.2 Why You Should Read This Report 1.3 Who is This Report For? 1.4 Methodology 1.4.1 Primary Research 1.4.2 Secondary Research 1.4.3 Market Evaluation & Forecasting Methodology 1.5 Frequently Asked Questions (FAQ) 1.6 Associated Visiongain Reports 1.7 About Visiongain 2. Introduction to the Urology Device Market 2.1 Urology Device Market Definition 2.2 Urology Device Market Submarkets Definition 2.2.1 Urinary Incontinence (UI) Market Definition 2.2.2 Benign Prostatic Hyperplasia Market Definition 2.2.3 Prostate Cancer Submarket Definition 2.2.4 Kidney Stone Submarket Definition 2.3 Market Drivers and Barriers 2.3.1 Market Drivers 2.3.1.1 High Target Population 2.3.1.3 Technological Innovations 2.3.1.4 Favourable Government Healthcare Policy and Funding 2.3.2 Market Restrainers 2.3.2.1 Safety Concerns 2.3.2.2 Barrier: Higher cost 3. SWOT Analysis of the Urology Device Market 4. Leading 20 Urology Device Companies 4.1 Leading 20 Urology Company Sales Share Analysis 2018 5. Key Company Profiles 5.1 KARL STORZ SE & Co KG 5.1.1 Company Overview 5.1.2. Business Overview 5.1.3 Geographical Presence 5.1.4 Product Offerings 5.1.5 Pipeline Analysis 5.1.6 Financial Overview 5.1.7 Strategic Developments 5.1.7.1 Medicaroid and KARL STORZ 5.1.7.2 KARL STORZ Endoscopy Enters into Distribution Agreement with LiveData 5.1.7.3 Recent Events 5.1.8. SWOT Analysis 5.1.8.1 Strengths 5.1.8.2 Weaknesses 5.1.8.3 Opportunities 5.1.8.4 Threats 5.2 Stryker Corporation 5.2.1 Company Overview 5.2.2 Business Overview 5.2.3 Geographical Presence 5.2.4 Product Offerings 5.2.5 Financial Information 5.2.6 Strategic Developments 5.2.7. SWOT Analysis 5.2.7.1 Strengths 5.2.7.2 Weaknesses 5.2.7.3 Opportunities 5.2.7.4 Threats 5.3 Medtronic 5.3.1 Company Overview 5.3.2 Business Overview 5.3.3 Geographical Presence 5.3.4 Product Offerings 5.3.5 Pipeline Product Overview 5.3.6 Financial Overview 5.3.7 Strategic Developments 5.3.8 SWOT Analysis 5.3.8.1 Strengths 5.3.8.2 Weaknesses 5.3.8.3 Opportunities 5.3.8.4 Threats 5.4 Intuitive Surgical Inc. 5.4.1 Company Overview 5.4.2 Business Overview 5.4.3 Geographical Presence 5.4.4 Product Offerings 5.4.5 Pipeline Product Overview 5.4.6 Financial Overview 5.4.7 SWOT Analysis 5.4.7.1 Strengths 5.4.7.2 Weaknesses 5.4.7.3 Opportunities 5.4.7.4 Threats 5.4.8 Strategic Developments 5.5 Boston Scientific Corporation 5.5.1 Company Overview 5.5.2 Business Overview 5.5.3 Geographical Presence 5.5.4 Product Offerings 5.5.5 Financial Information 5.5.6 Strategic Developments 5.5.7 SWOT Analysis 5.5.7.1 Strengths 5.5.7.2 Weaknesses 5.5.7.3 Opportunity 5.5.7.4 Threats 5.6 Cook Medical 5.6.1 Company Overview 5.6.2 Business Overview 5.6.3 Geographical Presence 5.6.4 Product Offerings 5.6.5 Strategic Developments 5.6.6 SWOT Analysis 5.6.6.1 Strengths 5.6.6.2 Weaknesses 5.6.6.3 Opportunities 5.6.6.4 Threats 5.7 Siemens Healthineers AG 5.7.1 Company Overview 5.7.2 Business Overview 5.7.3 Geographical Presence 5.7.4 Financial Information 5.7.5 Strategic Developments 5.7.6 SWOT Analysis 5.7.6.1 Strengths 5.7.6.2 Weaknesses 5.7.6.3 Opportunities 5.7.6.4 Threats 5.8 Olympus Corporation 5.8.1 Company Overview 5.8.2 Business Overview 5.8.3 Product Offerings 5.8.4 Pipeline Product Overview 5.8.5 Financial Overview 5.8.6 SWOT Analysis 5.8.6.1 Strengths 5.8.6.2 Weaknesses 5.8.6.3 Opportunities 5.8.6.4 Threats 5.8.7 Strategic Developments 5.8.7.1 M&A 5.8.7.2 Recent Development 5.9 Coloplast 5.9.1 Company Overview 5.9.2 Business Overview 5.9.3 Geographic Coverage 5.9.4 Major Products Offerings 5.9.5 Pipeline Overview 5.9.6 Financial Overview 5.9.7 SWOT Analysis 5.9.7.1 Strengths 5.9.7.2 Weaknesses 5.9.7.3 Opportunities 5.9.7.4 Threats 5.9.8 Strategic Developments 5.9.8.1 M&A 5.9.8.2 Recent Developments 5.10 Teleflex 5.10.1 Company Overview 5.10.2 Business Overview 5.10.3 Geographical Coverage 5.10.4 Products offerings 5.10.5 Pipeline Overview 5.10.6 Financial Information 5.10.7 Strategic Development 5.10.7.1 M&A 5.10.7.2 Recent Developments 5.10.8 SWOT Analysis 5.10.8.1 Strengths 5.10.8.2 Weaknesses 5.10.8.3 Opportunities 5.10.8.4 Threats 5.11 Endo Pharmaceuticals 5.11.1 Company Overview 5.11.2 Business Overview 5.11.4 Product Offerings 5.11.5 Pipeline Overview 5.11.6 Financial Overview 5.11.7 Strategic Development 5.11.7.1 M&A 5.11.7.2 Recent Developments 5.12 Healthtronics 5.12.1 Company Overview 5.12.2 Business Overview 5.12.3 Geographical Coverage 5.12.4 Product Offerings 5.12.5 SWOT Analysis 5.12.5.1 Strengths 5.12.5.2 Weaknesses 5.12.5.3 Opportunities 5.12.5.4 Threats 5.12.6 Financial Overview 5.12.7 M&A 5.13 Lumenis 5.13.1 Company Overview 5.13.2 Business Overview 5.13.3 Major Products Offerings 5.13.4 Financial Overview 5.13.5 SWOT Analysis 5.13.5.1 Strengths 5.13.5.2 Weaknesses 5.13.5.3 Opportunities 5.13.5.4 Threats 5.13.6 Strategic Development 5.13.6.1 Recent Development 5.14 C R Bard: (Becton, Dickinson) 5.14.1 Company Overview 5.14.2 Business Overview 5.14.3 Product Offerings 5.14.4 Geographic Presence 5.14.5 Pipeline Product Overview 5.14.6 SWOT Analysis 5.14.6.1 Strengths 5.14.6.2 Weaknesses 5.14.6.3 Opportunities 5.14.6.4 Threats 5.15 B.Braun Medical 5.15.1 Company Overview 5.15.2 Business Overview 5.15.3 Product Offerings 5.15.4 Pipeline Products 5.15.5 Financial Overviews 5.15.6 Recent Developments 5.16 Fresenius Medical 5.16.1 Company Overview 5.16.2 Business Overview 5.16.3 Product Offerings 5.16.4 Geographic Presence 5.16.5 Financial Overview 5.16.6 SWOT Analysis 5.16.6.1 Strengths 5.16.6.2 Weaknesses 5.16.6.3 Opportunities 5.16.6.4 Threats 5.17 Dornier MedTech GmbH 5.17.1 Company Overview 5.17.2 Business Overview 5.17.3 Product Offerings 5.17.4 Geographic Presence 5.17.5 Financial Overview: NA 5.18 NIKKISO CO. LTD 5.18.1 Company Overview 5.18.2 Business Overview 5.18.3 Product offerings 5.18.4 Geographical Presence 5.18.5 Financial Overview 5.18.6 SWOT Analysis 5.18.6.1 Strengths 5.18.6.2 Weaknesses 5.18.6.3 Opportunities 5.18.6.4 Threats 5.19 UROLOGIX 5.19.1 Company Overview 5.19.2 Business Overview 5.19.3 Products 5.19.4 Financial Overview 5.19.5 Recent Development 5.20 Urotech GmbH 5.20.1 Company Overview 5.19.2 Business Overview 5.20.3 Product Offerings 5.20.4 Financial Overview 6. Conclusions and Recommendations Associated Visiongain Reports Visiongain Report Sales Order Form About Visiongain Visiongain report evaluation form List of Tables Table 3.1 Global Urology Device Market SWOT Analysis Table 4.1 Leading 20 Urology Companies Sales Share 2018 (Ranking, Company, FY2018 Total Company Sales US$m, Share of FY2018 Total Sales from Sales in the Market US$m) Table 5.1 Karl Stroz Se & Co KG Table 5.2 KARL STORZ SE & Co KG - Number of Pipeline Product by Development Stage Table 5.3 KARL STORZ SE & Co KG - Number of Pipeline Products by Category Table 5.4 KARL STORZ SE & Co KG - Number of Pipeline Products by Territory Table 5.5 Stryker Corporation Table 5.6 Medtronic Table 5.7 Medtronic: Number of Pipeline Product by Indications Table 5.8 Medtronic: Number of Pipeline Products by Therapeutic Area Table 5.9 Intuitive Surgical Table 5.10 Intuitive Surgical: Pipeline Product Overview Table 5.11 Boston Scientific Corporation Table 5.12 Cook Medical Table 5.13 Siemens Healthineers AG Table 5.14 Olympus Corporation Table 5.15 Olympus Corporation: Number of Pipeline Products by Category Table 5.16 Olympus Corporation: Number of Pipeline Products by Type Table 5.17 Olympus Corporation: Number of Pipeline Products by Territory Table 5.18 Coloplast Table 5.19 Coloplast: Number of Pipeline Products by Development Stage Table 5.20 Coloplast: Number of Pipeline Products by Category Table 5.21 Coloplast: Number of Pipeline Products by Territory Table 5.22 Teleflex Table 5.23 Teleflex : Number of Pipeline Products by Development Stage Table 5.24 Teleflex: Number of Pipeline Products by Category Table 5.25 Teleflex: Number of Pipeline Products by Territory Table 5.26 Endo Pharmaceuticals Table 5.27 Endo Pharmaceutical: Number of Pipeline Products by Category Table 5.28 Endo Pharmaceutical: Number of Pipeline Products by Indication Table 5.29 Endo Pharmaceutical: Number of Pipeline Products by Development Stage Table 5.30 Healthtronics Table 5.31 Lumenis Table 5.32 CR Bard: Becton, Dickinson Table 5.33 BD: Number of Pipeline Products by Type Table 5.34 BD: Number of Pipeline Products by Territory Table 5.35 BD: Number of Pipeline Products by Development Stage Table 5.36 B.Braun Medical Table 5.37 Braun: Number of Pipeline Products by Type Table 5.38 Fresenius Medical Table 5.39 Dornier MedTech GmbH Table 5.40 Nikkiso Co.Ltd Table 5.41 Urologixo.Ltd Table 5.42 Urotech GmbH List of Figures Figure 5.1 Stryker Corporation: Financial Overview Net Sales, 2014-2018 Figure 5.2 Stryker Corporation: Financial Overview Net Earning, 2014-2018 Figure 5.3 Medtronic: Financial Overview, Net Sales, 2014-2018 Figure 5.4 Medtronic: Financial Overview, Operating Profit, 2014-2018 Figure 5.5 Medtronic: Financial Overview Net Income, 2014-2018 Figure 5.6 Medtronic: Financial Overview Divisionwise Performance, 2014-2018 Figure 5.7 Medtronic: Net Sales by Market Geography (2018) Figure 5.8 Intuitive Surgical: Financial Overview Net Sales, 2013-2017 Figure 5.9 Intuitive Surgical: Financial Overview Net Income, 2013-2017 Figure 5.10 Intuitive Surgical: Net Sales by Market Geography (2017) Figure 5.11 Boston Scientific Corporation: Revenue, 2013-2017 Figure 5.12 Boston Scientific Corporation: Net Income, 2013-2017 Figure 5.13 Boston Scientific Corporation: Net Sales by Country (2018) Figure 5.14 Siemens Healthineers AG: Revenue 2014-2018 Figure 5.15 Siemens Healthineers AG: Net Income, 2015-2018 Figure 5.16 Siemens Healthineers AG: Revenue by Region (2018) Figure 5.17 Olympus Corporation: Net Sales, 2014-2018 Figure 5.18 Olympus Corporation: Operating Profit 2014-2018 Figure 5.19 Olympus Corporation: Revenue by Region (2018) Figure 5.20 Olympus Corporation: Revenue By Product Sub Segment (2018) Figure 5.21 Olympus Corporation: Revenue by Product Segment (2018) Figure 5.22 Coloplast: Net Sales, 2014-2018 Figure 5.23 Coloplast: Operating Profit, 2014-2018 Figure 5.24 Coloplast: Revenue by Region (2018) Figure 5.25 Teleflex: Net Sales, 2013-2017 Figure 5.26 Teleflex: Revenue by Categories (2017) Figure 5.27 Teleflex: Revenue by Region (2017) Figure 5.28 Endo Pharmaceutical: Net Sales, 2014-2018 Figure 5.29 BD: Financial Overview- Revenue, 2014-2018 Figure 5.30 BD: Financial Overview- Net Sales, 2014-2018 Figure 5.31 BD: Financial Overview- Operating Profit, 2014-2018 Figure 5.32 BD: Revenue by Product Category (2018) Figure 5.33 Braun: Financial Overview- Revenue, 2014-2017 Figure 5.34 Fresenius Medical: Financial Overview- Operating Profit, 2014-2018 Figure 5.35 Fresenius Medical: Financial Overview- Revenue, 2014-2018 Figure 5.36 Fresenius Medical: Financial Overview- Net Profit, 2014-2018 Figure 5.37 Nikkiso Co.Ltd: Financial Overview- Net Sales, 2014-2018 Figure 5.38 Nikkiso Co.Ltd: Financial Overview- Operating Profit, 2014-2018 Figure 5.39 Nikkiso Co.Ltd: Financial Overview- Medical Division Sales, 2016-2017, 2020F Figure 5.40 Nikkiso Co.Ltd: Revenue by Region, 2017